hTERT Represents an Innovative Bio-marker in Cholangiocarcinoma Detection
Abstract Background: The study was aimed to examine the diagnostic value of serum human telomerase reverse transcriptiptase (hTERT) in patients with cholangiocarcinoma (CCA).Methods: Serum hTERT in CCA patients and healthy controls was detected by quantitative real-time PCR (qRT-PCR) and compared by student’s t-test. Relationships of serum hTERT and clinical parameters were explained by Chi-square test. The receiver operating characteristics (ROC) analysis was conducted to identify the diagnostic value of serum hTERT in CCA.Results: Serum hTERT was up-regulated in CCA patients compared with healthy controls (P<0.05). Furthermore, serum hTERT was closely related with differentiation (P=0.005), distant metastasis (P=0.015) and TNM stage (P=0.009). The AUC value of ROC curve was 0.901, demonstrating that serum hTERT could discriminate between CCA and healthy individuals, with the cutoff point of 1.88. Besides, the diagnostic specificity and sensitivity of serum hTERT in CCA were 89.7% and 76.0%, respectively.Conclusions: hTERT may be a promising biomarker for diagnosis of CCA.